menu search

Manganese x energy completes final processing metallurgical phase for battery hill pea, highlighted by novel purification process

Manganese X Energy Corp (TSX-V:MN, OTCQB:MNXXF) has wrapped up the third and final processing metallurgical phase for the upcoming preliminary economi...

February 1, 2022, 9:21 am

Thermo fisher (tmo) base sales rebound, bioproduction in focus

Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used...

January 27, 2022, 1:04 pm

Thermo fisher (tmo) base sales rebound, bioproduction in focus

Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used...

January 27, 2022, 1:04 pm

Thermo fisher (tmo) base sales rebound, bioproduction in focus

Thermo Fisher (TMO) is currently expanding its bioproduction purification resin capacity, which is used...

January 27, 2022, 1:04 pm

Cabot: a few interesting developments

CBT's decision to sell its purification Solutions division should be taken well. CBT's Investor Day to ...

November 29, 2021, 1:06 pm

Cabot: a few interesting developments

CBT's decision to sell its purification Solutions division should be taken well. CBT's Investor Day to ...

November 29, 2021, 1:06 pm

Cabot: a few interesting developments

CBT's decision to sell its purification Solutions division should be taken well. CBT's Investor Day to ...

November 29, 2021, 1:06 pm

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm


Search within

Pages Search Results: